Michael Thomas Heffernan
Insider Reports History
- Location
- Wayne, PA
- Signature
- /s/ Lee Giguere, as attorney-in-fact for the Reporting Person
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Michael Thomas Heffernan:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC | Director | Common Stock | 50,328 | $1,536,011 | $30.52 | 10 Feb 2025 | Direct |
| Akebia Therapeutics, Inc. | Director | Common Stock | 48,586 | $59,416 | $1.22 | 02 Jun 2021 | Direct |
| enGene Holdings Inc. | Director | Stock Option (Right to Buy) | 45,000 | 08 Jul 2025 | Direct | ||
| Trevi Therapeutics, Inc. | Director | Nonstatutory Stock Option (right to buy) | 45,000 | 11 Jun 2025 | Direct | ||
| Biohaven Ltd. | Director | Stock Options (Right to buy) | 31,716 | 05 May 2025 | Direct | ||
| SYNLOGIC, INC. | Director | Stock Option (right to buy) | 30,000 | 22 Jun 2023 | Direct | ||
| Avalo Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 29,500 | 17 Jun 2025 | Direct | ||
| Akebia Therapeutics, Inc. | Director | Stock Option (Right to buy) | 20,100 | 02 Jun 2021 | Direct | ||
| Biohaven Pharmaceutical Holding Co Ltd. | Director | Restricted Share Unit Award | 0 | 03 Oct 2022 | Direct | ||
| Biohaven Pharmaceutical Holding Co Ltd. | Director | Stock Options (Right to Buy) | 0 | 03 Oct 2022 | Direct |